TrialDiabetes care2023

Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes.

Christof M Kazda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.